O	0	12	Experimental	Experimental	JJ	B-NP
O	13	17	drug	drug	NN	I-NP
O	18	25	therapy	therapy	NN	I-NP
O	26	28	of	of	IN	B-PP
B-Pathological_formation	29	40	peritumoral	peritumoral	JJ	B-NP
I-Pathological_formation	41	46	brain	brain	NN	I-NP
I-Pathological_formation	47	52	edema	edema	NN	I-NP
O	52	53	.	.	.	O

O	54	58	Four	Four	CD	B-NP
O	59	64	drugs	drug	NNS	I-NP
O	65	69	with	with	IN	B-PP
O	70	79	potential	potential	JJ	B-NP
O	80	84	anti	anti	AFX	I-NP
O	84	85	-	-	HYPH	I-NP
B-Pathological_formation	85	96	peritumoral	peritumoral	JJ	I-NP
I-Pathological_formation	97	102	brain	brain	NN	I-NP
I-Pathological_formation	103	108	edema	edema	NN	I-NP
O	109	117	activity	activity	NN	I-NP
O	118	122	were	be	VBD	B-VP
O	123	130	studied	study	VBN	I-VP
O	131	136	using	use	VBG	B-VP
O	137	140	the	the	DT	B-NP
B-Cancer	141	144	VX2	VX2	NN	I-NP
O	145	151	rabbit	rabbit	NN	I-NP
B-Cancer	152	157	brain	brain	NN	I-NP
I-Cancer	158	163	tumor	tumor	NN	I-NP
O	164	169	model	model	NN	I-NP
O	169	170	.	.	.	O

O	171	184	Meclofenamate	Meclofenamate	NN	B-NP
O	185	188	and	and	CC	I-NP
O	189	201	indomethacin	indomethacin	NN	I-NP
O	202	206	were	be	VBD	B-VP
O	207	213	tested	test	VBN	I-VP
O	214	216	in	in	IN	B-PP
O	217	219	an	an	DT	B-NP
O	220	227	attempt	attempt	NN	I-NP
O	228	230	to	to	TO	B-VP
O	231	238	confirm	confirm	VB	I-VP
O	239	245	recent	recent	JJ	B-NP
O	246	253	reports	report	NNS	I-NP
O	254	256	of	of	IN	B-PP
O	257	261	anti	anti	AFX	B-NP
O	261	262	-	-	HYPH	I-NP
B-Pathological_formation	262	267	edema	edema	NN	I-NP
O	268	276	activity	activity	NN	I-NP
O	277	279	in	in	IN	B-PP
O	280	283	non	non	JJ	B-NP
O	284	293	steroidal	steroidal	JJ	I-NP
O	294	298	anti	anti	AFX	B-NP
O	298	299	-	-	HYPH	I-NP
O	299	311	inflammatory	inflammatory	JJ	I-NP
O	312	317	drugs	drug	NNS	I-NP
O	318	319	(	(	(	O
O	319	324	NSAID	NSAID	NN	B-NP
O	324	325	'	'	''	I-NP
O	325	326	s	s	NNS	I-NP
O	326	327	)	)	)	O
O	327	328	.	.	.	O

O	329	332	The	The	DT	B-NP
O	333	334	'	'	``	I-NP
O	334	345	angiostatic	angiostatic	JJ	I-NP
O	345	346	'	'	''	I-NP
O	347	355	steroids	steroid	NNS	I-NP
O	356	358	17	17	CD	B-NP
O	359	378	hydroxyprogesterone	hydroxyprogesterone	NN	I-NP
O	379	382	and	and	CC	I-NP
O	383	394	epicortisol	epicortisol	NN	I-NP
O	395	399	were	be	VBD	B-VP
O	400	406	tested	test	VBN	I-VP
O	407	414	because	because	IN	B-PP
O	415	417	of	of	IN	I-PP
O	418	423	their	their	PRP$	B-NP
O	424	428	lack	lack	NN	I-NP
O	429	431	of	of	IN	B-PP
O	432	446	glucocorticoid	glucocorticoid	NN	B-NP
O	447	450	and	and	CC	I-NP
O	451	468	mineralocorticoid	mineralocorticoid	NN	I-NP
O	469	476	effects	effect	NNS	I-NP
O	477	480	and	and	CC	O
O	481	486	their	their	PRP$	B-NP
O	487	497	structural	structural	JJ	I-NP
O	498	508	similarity	similarity	NN	I-NP
O	509	511	to	to	TO	B-PP
O	512	527	glucocorticoids	glucocorticoid	NNS	B-NP
O	527	528	.	.	.	O

O	529	532	The	The	DT	B-NP
O	533	540	protein	protein	NN	I-NP
O	541	544	and	and	CC	I-NP
O	545	550	water	water	NN	I-NP
O	551	560	component	component	NN	I-NP
O	561	563	of	of	IN	B-PP
B-Pathological_formation	564	569	brain	brain	NN	B-NP
I-Pathological_formation	570	575	edema	edema	NN	I-NP
O	576	580	were	be	VBD	B-VP
O	581	591	indirectly	indirectly	RB	I-VP
O	592	603	quantitated	quantitate	VBN	I-VP
O	603	604	.	.	.	O

O	605	609	None	None	NN	B-NP
O	610	612	of	of	IN	B-PP
O	613	616	the	the	DT	B-NP
O	617	621	test	test	NN	I-NP
O	622	627	drugs	drug	NNS	I-NP
O	628	640	demonstrated	demonstrate	VBD	B-VP
O	641	652	significant	significant	JJ	B-NP
O	653	657	anti	anti	AFX	I-NP
O	657	658	-	-	HYPH	I-NP
B-Pathological_formation	658	663	edema	edema	NN	I-NP
O	664	672	activity	activity	NN	I-NP
O	672	673	.	.	.	O

O	674	678	This	This	DT	B-NP
O	679	683	work	work	NN	I-NP
O	684	688	does	do	VBZ	B-VP
O	689	692	not	not	RB	I-VP
O	693	700	confirm	confirm	VB	I-VP
O	701	708	reports	report	NNS	B-NP
O	709	713	that	that	IN	B-SBAR
O	714	719	NSAID	NSAID	NN	B-NP
O	719	720	'	'	''	B-NP
O	720	721	s	s	NNS	I-NP
O	722	726	have	have	VBP	B-VP
O	727	731	anti	anti	AFX	B-NP
O	731	732	-	-	HYPH	I-NP
B-Pathological_formation	732	737	edema	edema	NN	I-NP
O	738	746	activity	activity	NN	I-NP
O	747	750	and	and	CC	O
O	751	759	suggests	suggest	VBZ	B-VP
O	760	764	that	that	IN	B-SBAR
O	765	770	there	there	EX	B-NP
O	771	774	may	may	MD	B-VP
O	775	777	be	be	VB	I-VP
O	778	780	no	no	DT	B-NP
O	781	792	correlation	correlation	NN	I-NP
O	793	800	between	between	IN	B-PP
O	801	802	'	'	``	B-NP
O	802	813	angiostatic	angiostatic	JJ	I-NP
O	813	814	'	'	''	O
O	815	818	and	and	CC	O
O	819	823	anti	anti	AFX	B-NP
O	823	824	-	-	HYPH	I-NP
B-Pathological_formation	824	829	edema	edema	NN	I-NP
O	830	838	activity	activity	NN	I-NP
O	839	841	in	in	IN	B-PP
O	842	849	certain	certain	JJ	B-NP
O	850	857	steroid	steroid	NN	I-NP
O	858	867	compounds	compound	NNS	I-NP
O	867	868	.	.	.	O

